Hope Medicine
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Developing targeted immunology and oncology therapies to address autoimmune diseases and cancer.
ImmunologyOncology
Technology Platform
Focuses on discovering and developing targeted immunomodulators for both suppressing autoimmune responses and activating anti-cancer immunity.
Opportunities
The vast and growing patient populations for autoimmune diseases and cancer in China provide a substantial addressable market for effective new therapies.
Risk Factors
Clinical failure risk is high given the complexity of immune system modulation and the crowded nature of its target markets.
Competitive Landscape
Enters highly crowded markets dominated by global blockbusters, competing on innovation and potential best-in-class profiles for niche indications.